Drug & Alcohol Rehabilitation Clinics in the US: Market Size, Businesses & Forecast 2026

The Drug & Alcohol Rehabilitation Clinics industry in the United States comprises establishments providing inpatient, residential, and outpatient treatment for individuals suffering from substance use disorders and co-occurring mental health conditions. According to the Substance Abuse and Mental Health Services Administration (SAMHSA) National Substance Use and Mental Health Services Survey (N-SUMHSS) published in 2024, the United States substance use treatment infrastructure relied on a network of 14,845 active treatment facilities. The industry is moving toward greater integration of medication-assisted treatments and specialized care tracks as it addresses a persistent public health need

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Drug & Alcohol Rehabilitation Clinics in the US industry cover?

The industry encompasses facilities dedicated to delivering medical, psychological, and rehabilitative care to individuals experiencing chemical dependencies on drugs or alcohol. Services are delivered across multiple tiers of care based on patient acuity, ranging from short-term acute inpatient detoxification to highly flexible outpatient programs. While some operators provide standalone addiction services, contemporary models heavily emphasize comprehensive dual-diagnosis programs that simultaneously treat underlying or co-occurring mental health disorders.

• •Primary classification falls under NAICS code 623220 for residential centers and NAICS code 621420 for outpatient clinics.
• •The 2024 SAMHSA N-SUMHSS data reveals that 83% of specialized substance use facilities offer outpatient care.
• •Residential care settings are utilized by 24% of substance use treatment facilities to provide structured, long-term therapeutic environments.

Who operates in the industry and how is it structured?

The operational structure of the industry is highly diverse, split between private commercial businesses, non-profit institutions, and government-administered facilities. Private non-profit organizations and private for-profit corporations represent the overwhelming majority of service locations nationwide, while federal, state, and local governments manage a small baseline network of facilities. Facilities frequently tailor their programming to target specific underserved demographics or high-risk populations to secure targeted public grant funding.

• •Private non-profit organizations operated 4,670 substance use facilities according to the 2024 SAMHSA survey.
• •Private for-profit corporations accounted for the largest operational share, maintaining 7,858 active facilities.
• •Tailored programs for specific cohorts are common, with 51% of dual substance use and mental health facilities offering targeted adolescent tracks.

What drives demand in the industry?

The necessity for professional rehabilitation services is primarily driven by shifting public health trends, specifically the prevalence of illicit substance dependencies and prescription opioid crises. Societal awareness and the reduction of cultural stigmas surrounding behavioral health treatment have steadily funneled a higher percentage of affected individuals into formal clinical settings. Furthermore, federal legislations that require commercial health insurance plans to provide equitable coverage for behavioral health services have significantly lowered financial barriers to entry for millions of citizens.

• •The Mental Health Parity and Addiction Equity Act (MHPAEA) enforces equal insurance coverage limits for substance use therapies.
• •The expansion of Medicaid eligibility under federal guidelines acts as a critical structural funding source for low-income treatment seeking.
• •Increases in government grant disbursements, such as the Substance Abuse Prevention and Treatment Block Grant (SABG), directly bolster clinic capacities.

Who are the notable companies in the industry?

The competitive environment is fragmented and characterized by a vast number of localized, independent single-site operators alongside a select group of heavily consolidated national behavioral health networks. Large healthcare entities scale operations by executing regional acquisitions and building integrated healthcare systems that manage full continuums of behavioral care. These prominent operators utilize substantial capital resources to maintain compliance with rigorous medical auditing bodies and to negotiate comprehensive reimbursement rates with private commercial insurers.

• •Acadia Healthcare Company, Inc. operates as a leading pure-play behavioral health provider with an expansive network of substance use clinics.
• •Universal Health Services, Inc. maintains a large national footprint of acute behavioral health hospitals and specialized substance abuse facilities.
• •Rogers Behavioral Health operates as a major multi-state, independent non-profit provider specializing in addiction and co-occurring disorders.
• •U.S. Behavioral Health Plan, California (a subsidiary of UnitedHealth Group) exerts strong market influence via managed care networks and structured provider panels.

How is the industry regulated?

Rehabilitation clinics operate under strict oversight from both federal authorities and individual state licensing boards to guarantee patient safety and evidence-based care delivery. Facilities are subject to detailed privacy laws governing substance use disorder patient records, which dictate much higher confidentiality thresholds than standard medical charting. Clinical efficacy and operational standards are routinely vetted by independent, non-governmental accreditation organizations, which serve as a baseline requirement for receiving commercial insurance reimbursements.

• •The Substance Abuse and Mental Health Services Administration (SAMHSA) regulates the certification of specialized Opioid Treatment Programs.
• •The Code of Federal Regulations Title 42 Part 2 enforces strict confidentiality mandates protecting substance use patient identity and treatment data.
• •The Joint Commission and the Commission on Accreditation of Rehabilitation Facilities (CARF) act as the primary external clinical accreditors.

Government, statistical and trade sources used for this Claight analysis.

• SAMHSA National Substance Use and Mental Health Services Survey 2024 ·
• U.S. Census Bureau North American Industry Classification System 2022 ·
• Centers for Medicare & Medicaid Services Parity Compliance Guidelines